Prognostic serum biomarkers by COVID-19

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026655

Enrollment

Registered

2021-11-26

Start date

2021-12-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J12.8

Interventions

Group 1: Patients with severe COVID-19 with need of mechanical ventillatory support and/or extracorporal membrane oxygenation. Serum furin and NT-proCNP level will be measured in freezed samples, draw

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Deep frozen serum samples of matched (age, sex, diabetes mellitus, nicotin consume and body weight) patients with SARS-Cov2 infection and control patients are going to be analised.

Exclusion criteria

Exclusion criteria: n.a.

Design outcomes

Primary

Measure	Time frame
Aim of this study to define novel prognositc biomarker by COVID-19	—

Secondary

Measure	Time frame
Correlation of serum furin and CNP levels with the course of COVID-19	—

Countries

Germany

Contacts

Public ContactIstvan Bojti

Universitätsklinikum Freiburg

istvan.bojti@uniklinik-freiburg.de+4915780802912

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 9, 2026